Azido flufenamiko
- Oharra: Wikipediak ez du mediku aholkurik ematen. Tratamendua behar duzula uste baduzu, jo ezazu sendagilearengana.
Azido flufenamiko | |
---|---|
Formula kimikoa | C14H10F3NO2 |
SMILES kanonikoa | 2D eredua |
MolView | 3D eredua |
Mota | konposatu kimiko |
Ezaugarriak | |
Fusio-puntua | 134 °C |
Masa molekularra | 281,066 Da |
Erabilera | |
Elkarrekintza | Anoctamin 1 (en) , Gap junction protein beta 7 (en) , Gap junction protein beta 2 (en) , gap junction protein beta 6 (en) , Gap junction protein gamma 3 (en) , Gap junction protein beta 4 (en) , Gap junction protein beta 3 (en) , Gap junction protein beta 5 (en) , Gap junction protein delta 3 (en) , Gap junction protein beta 1 (en) , Gap junction protein delta 2 (en) , Gap junction protein alpha 4 (en) , Gap junction protein alpha 5 (en) , Gap junction protein delta 4 (en) , Gap junction protein alpha 1 (en) , Gap junction protein gamma 1 (en) , Gap junction protein alpha 3 (en) , Gap junction protein gamma 2 (en) , Gap junction protein alpha 8 (en) , Gap junction protein alpha 9 (en) , Gap junction protein alpha 10 (en) , Pannexin 1 (en) , Pannexin 2 (en) , Pannexin 3 (en) , Transient receptor potential cation channel subfamily C member 5 (en) , Transient receptor potential cation channel subfamily M member 2 (en) , Transient receptor potential cation channel, subfamily M, member 4 (en) , Transient receptor potential cation channel subfamily M member 5 (en) eta Polycystin 2 like 1, transient receptor potential cation channel (en) |
Rola | antiinflamatorio |
Identifikatzaileak | |
InChlKey | LPEPZBJOKDYZAD-UHFFFAOYSA-N |
CAS zenbakia | 530-78-9 |
ChemSpider | 3254 |
PubChem | 3371 |
Reaxys | 1996069 |
Gmelin | 42638 |
ChEBI | 1327188 |
ChEMBL | CHEMBL23588 |
EC zenbakia | 208-494-1 |
ECHA | 100.007.723 |
MeSH | D005439 |
RxNorm | 4453 |
Human Metabolome Database | HMDB0252331 |
UNII | 60GCX7Y6BH |
KEGG | D01581 |
PDB Ligand | FLF |
Azido flufenamikoa[1] antiinflamatorio ez esteroideo familiako botika da. Azido fenamiko edo fenamatoaren deribatua,[2] analgesiko eta antipiretikoa ere bada.
2020ko urrian, FDAk medikamentuaren etiketa hanturaren aurkako sendagai ez esteroide guztietarako eguneratzea eskatu zuen, jaiotzeagatiko giltzurrun-arazoen arriskua deskribatzeko, likido amniotikoaren maila baxuan gertatzen baitira.[3]
Erreferentziak
- ↑ Euskalterm: [Farmakoak Hiztegia] [2022]
- ↑ (Gaztelaniaz) Linda Lane Lilley, Robert S. Aucker, Richard E. Lake, Roberto Gómez del Campo.. (1999). Farmacologia en Enfermeria. Elsevier España, 613 or. ISBN 84-8174-448-4..
- ↑ (Ingelesez) Center for Drug Evaluation and Research. (2020-10-27). FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. FDA.
Kanpo estekak
- Datuak: Q416341
- Multimedia: Flufenamic acid / Q416341
Artikulu hau medikuntzari buruzko zirriborroa da. Wikipedia lagun dezakezu edukia osatuz. |